Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

The researchers found that dry powder triple inhaler therapy of fluticasone-umeclidinium-vilanterol resulted in fewer COPD exacerbations compared to metered dose triple inhaler therapy of ...

Mylan has launched its generic version ... The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016.

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate ... patients to double the dose of their inhaled corticosteroid medication for a ...

The generic drug, montelukast should be offered to people ahead of combination inhalers such as ... combinations such as Seretide (salmeterol and fluticasone) are often given.

Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

1. In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was not associated with improved clinical outcomes compared to receiving ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and production capabilities. Pharmaceutical customers can now leverage the ...